Lpl Financial LLC Novo Cure LTD Transaction History

Lpl Financial LLC

  • $238 Billion
  • Q4 2024

A detailed history of Lpl Financial LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Lpl Financial LLC holds 27,861 shares of NVCR stock, worth $614,335. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,861
Holding current value
$614,335
% of portfolio
0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$14.54 - $33.41 $405,098 - $930,836
27,861 New
27,861 $830,000
Q2 2024

Aug 07, 2024
SELL
$11.83 - $24.05 $36,874 - $74,963
-3,117 Reduced 17.54%
14,651 $250,000
Q1 2024

May 10, 2024
SELL
$12.42 - $17.29 $36,514 - $50,832
-2,940 Reduced 14.2%
17,768 $277,000
Q4 2023

Feb 14, 2024
BUY
$11.13 - $15.78 $57,252 - $81,172
5,144 Added 33.05%
20,708 $309,000
Q3 2023

Nov 13, 2023
SELL
$16.15 - $42.35 $125,582 - $329,313
-7,776 Reduced 33.32%
15,564 $251,000
Q2 2023

Jul 31, 2023
SELL
$40.29 - $82.51 $29,250 - $59,902
-726 Reduced 3.02%
23,340 $968,000
Q1 2023

May 10, 2023
SELL
$56.44 - $118.81 $43,458 - $91,483
-770 Reduced 3.1%
24,066 $1.45 Million
Q4 2022

Feb 07, 2023
BUY
$63.98 - $85.37 $170,826 - $227,937
2,670 Added 12.05%
24,836 $1.82 Million
Q3 2022

Nov 14, 2022
BUY
$67.99 - $89.57 $190,711 - $251,243
2,805 Added 14.49%
22,166 $1.68 Million
Q2 2022

Aug 12, 2022
BUY
$56.6 - $89.9 $36,903 - $58,614
652 Added 3.48%
19,361 $1.35 Million
Q1 2022

May 16, 2022
SELL
$60.15 - $84.52 $257,863 - $362,337
-4,287 Reduced 18.64%
18,709 $1.55 Million
Q4 2021

Feb 14, 2022
BUY
$75.08 - $121.99 $39,116 - $63,556
521 Added 2.32%
22,996 $1.73 Million
Q3 2021

Nov 15, 2021
BUY
$116.17 - $194.55 $620,928 - $1.04 Million
5,345 Added 31.2%
22,475 $2.61 Million
Q2 2021

Aug 13, 2021
SELL
$130.4 - $225.58 $39,511 - $68,350
-303 Reduced 1.74%
17,130 $3.8 Million
Q1 2021

May 14, 2021
SELL
$124.11 - $190.17 $895,577 - $1.37 Million
-7,216 Reduced 29.28%
17,433 $2.3 Million
Q4 2020

Feb 12, 2021
SELL
$112.16 - $174.14 $102,065 - $158,467
-910 Reduced 3.56%
24,649 $4.27 Million
Q3 2020

Nov 09, 2020
BUY
$58.05 - $111.31 $87,655 - $168,078
1,510 Added 6.28%
25,559 $2.85 Million
Q2 2020

Aug 13, 2020
BUY
$57.2 - $74.41 $216,845 - $282,088
3,791 Added 18.71%
24,049 $1.43 Million
Q1 2020

May 14, 2020
BUY
$57.05 - $95.75 $263,513 - $442,269
4,619 Added 29.54%
20,258 $1.36 Million
Q4 2019

Feb 14, 2020
BUY
$68.3 - $93.8 $26,705 - $36,675
391 Added 2.56%
15,639 $1.32 Million
Q3 2019

Nov 13, 2019
SELL
$61.86 - $97.8 $539,171 - $852,424
-8,716 Reduced 36.37%
15,248 $1.14 Million
Q2 2019

Aug 09, 2019
BUY
$42.22 - $63.23 $433,514 - $649,245
10,268 Added 74.97%
23,964 $1.52 Million
Q1 2019

May 08, 2019
SELL
$31.96 - $56.12 $2,780 - $4,882
-87 Reduced 0.63%
13,696 $660,000
Q4 2018

Feb 07, 2019
BUY
$28.72 - $52.63 $395,847 - $725,399
13,783 New
13,783 $461,000

Others Institutions Holding NVCR

# of Institutions
288
Shares Held
75.6M
Call Options Held
1.77M
Put Options Held
538K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $2.31B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Lpl Financial LLC Portfolio

Follow Lpl Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email